What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0000820434
Total reported value
$173.2M
$173.2M
36 檔
7.0%
As reported in its official Q2 2024 Form 13F filing, Pvg Asset Management CORP's tracked investment portfolio stood at $173.2M with 36 total positions.
During Q2 2024, Pvg Asset Management CORP's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BIL | Ss Spdr Bb 1-3m T-bill ETF | ETF-Gov Bonds | 12.82% | -12.44% | -40.84% | |
| 2 | IVV | Ishares Core S&p 500 ETF | ETF-Large Cap & Growth | 11.71% | -1.90% | -4.27% | |
| 3 | SDS | ProShares UltraShort S&P500 | Stock-Other | 10.83% | — | +95.65% | |
| 4 | VOO | Vanguard S&p 500 ETF | ETF-Large Cap & Growth | 6.55% | -3.60% | -7.03% | |
| 5 | XBXMX | Nuveen S&p 500 Buy-wr Inc | Stock-Other | 6.07% | — | — | |
| 6 | MGF | Mfs Govt Markets Inc Trust | Stock-Other | 5.70% | -0.17% | — | |
| 7 | XLE | Ss Energy Select Sector | ETF-Other | 3.89% | — | — | |
| 8 | JNJ | Johnson & Johnson | Stock-Healthcare | 3.69% | — | NEW | |
| 9 | DX | Dynex Capital Inc | Stock-Other | 3.62% | -0.79% | — | |
| 10 | DERM | Journey Medical CORP | Stock-Other | 3.54% | -0.85% | — | |
| 11 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 2.68% | -1.87% | -13.04% | |
| 12 | MGK | Vanguard Mega Cap Growth ETF | ETF-Other | 2.25% | — | — | |
| 13 | VERUEUR | Veru Inc | Stock-Other | 1.88% | — | — | |
| 14 | XBIL | F/m US Treasury 6 Month Bill | ETF-Gov Bonds | 1.88% | — | — | |
| 15 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 1.67% | -0.86% | +30.28% | |
| 16 | KBWB | Invesco Kbw Bank ETF | ETF-Other | 1.65% | — | — | |
| 17 | IBB | Ishares Biotechnology ETF | ETF-Tech | 1.64% | — | — | |
| 18 | PSQ | Proshares Short Qqq | ETF-Other | 1.50% | — | — | |
| 19 | AGNC | Agnc Investment CORP | Stock-Real Estate | 1.46% | -0.46% | — | |
| 20 | BUG | Global X Cybersecurity ETF | ETF-Other | 1.31% | — | — | |
| 21 | FINX | Global X Fintech ETF | ETF-Tech | 1.23% | — | — | |
| 22 | ✓ | Stock-Other | 1.17% | — | +18.91% | ||
| 23 | AMD | Advanced Micro Devices | Stock-Tech | 1.13% | -1.05% | — | |
| 24 | FBIO | Fortress Biotech Inc | Stock-Other | 1.05% | -0.30% | EXIT | |
| 25 | RTX | Rtx CORP | Stock-Industrials | 1.05% | — | -39.19% | |
| 26 | USRT | Ishares Core US Reit ETF | ETF-Other | 1.02% | — | — | |
| 27 | ✓ | MSC Income Fund Inc. (mscf) | Stock-Other | 0.90% | — | -0.00% | |
| 28 | ULST | Ss Ultra Short Tm Bond ETF | ETF-Other | 0.89% | — | -49.35% | |
| 29 | BXSL | Blackstone Secured Lending F | Stock-Financials | 0.87% | — | NEW | |
| 30 | T | At&t Inc | Stock-Comm Services | 0.84% | — | -49.63% | |
| 31 | HPQ | Hp Inc | Stock-Tech | 0.84% | — | — | |
| 32 | ✓ | Fs Specialty Lending Fund | Stock-Other | 0.81% | — | — | |
| 33 | CPRX | Catalyst Pharmaceuticals Inc | Stock-Healthcare | 0.72% | — | -33.02% | |
| 34 | ALT | Altimmune Inc | Stock-Other | 0.61% | — | NEW | |
| 35 | ✓ | Biolinerx LTD Adr | Stock-Other | 0.28% | — | +99.84% | |
| 36 | RCAT | Red Cat Holdings Inc | Stock-Other | 0.25% | — | -78.96% |
According to official SEC Form 13F filings, Pvg Asset Management CORP reported a total U.S. public equity portfolio value of $173.2M across 36 disclosed positions in Q2 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including BIL, IVV, SDS) accounted for 7.0% of total reported equity market value during Q2 2024.
During Q2 2024, Pvg Asset Management CORP's top holdings by market value included BIL (12.8%)、IVV (11.7%)、SDS (10.8%). The largest single position, BIL, represented 12.8% of total portfolio value.
In Q2 2024, Pvg Asset Management CORP made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.